Atara Biotherapeutics (ATRA) Net Income (QoQ) (2013 - 2026)
Atara Biotherapeutics (ATRA) Net Income (QoQ) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Nanobiotix | 1,827.19 Bn | 1,827.13 Bn | - |
| 2 | Akari Therapeutics | 1,006.47 Bn | 1,006.47 Bn | - |
| 3 | BeOne Medicines | 475.45 Bn | 470.65 Bn | 1.35 Bn |
| 4 | Vertex Pharmaceuticals | 123.32 Bn | 116.08 Bn | 2.59 Bn |
| 5 | Regeneron Pharmaceuticals | 71.31 Bn | 62.56 Bn | 3.31 Bn |
| 6 | Belite Bio | 62.61 Bn | 62.61 Bn | - |
| 7 | Argenx Se | 55.56 Bn | 50.38 Bn | 1.41 Bn |
| 8 | Alnylam Pharmaceuticals | 37.96 Bn | 34.96 Bn | 959.66 Mn |
| 9 | Revolution Medicines | 37.20 Bn | 37.20 Bn | - |
| 10 | Atara Biotherapeutics | 109.27 Mn | 100.91 Mn | 392,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -22.34% |
| Dec 31, 2025 | 21.26% |
| Sep 30, 2025 | -280.27% |
| Jun 30, 2025 | -93.72% |
| Mar 31, 2025 | 399.46% |
| Dec 31, 2024 | 42.06% |
| Sep 30, 2024 | -15.01% |
| Jun 30, 2024 | 40.01% |
| Mar 31, 2024 | 47.47% |
| Dec 31, 2023 | 13.39% |
| Sep 30, 2023 | 1.84% |
| Jun 30, 2023 | 4.90% |
| Mar 31, 2023 | -0.27% |
| Dec 31, 2022 | 11.32% |
| Sep 30, 2022 | -555.38% |
| Jun 30, 2022 | 120.96% |
| Mar 31, 2022 | 5.83% |
| Dec 31, 2021 | -10.50% |
| Sep 30, 2021 | -1.04% |
| Jun 30, 2021 | -6.97% |